AVP
EmergingAVP regulates water balance; copeptin, a more stable related marker, is now preferred for diagnosing water-balance disorders.
AVP controls how much water the kidneys hold onto. Too little causes excessive urination (diabetes insipidus); too much causes dangerously low blood sodium (SIADH). Since AVP itself is hard to measure reliably, doctors now typically test a more stable related marker called copeptin instead.
Arginine vasopressin (AVP), also called antidiuretic hormone, is a pituitary hormone regulating water balance by controlling how much water the kidneys reabsorb.
Deficient AVP causes diabetes insipidus (excessive dilute urination), while excessive AVP causes SIADH (syndrome of inappropriate antidiuretic hormone secretion), leading to dangerously low blood sodium.
Because AVP itself is technically difficult to measure reliably (it's unstable in blood samples), copeptin (a more stable co-secreted fragment from the same precursor molecule) has become the preferred practical surrogate marker in current clinical use for distinguishing these water-balance disorders.
A copeptin-based diagnostic protocol (with or without hypertonic saline stimulation) is now often preferred over the older water deprivation test for diagnosing diabetes insipidus, offering a faster, less burdensome diagnostic pathway for patients.
A copeptin-based diagnostic protocol increasingly replaces the older, more burdensome water deprivation test.
- General endocrinology reference literature on AVP/copeptin testing in diabetes insipidus and SIADH diagnosis.